Title : Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis - Trindade-da-Silva_2017_J.Pharmacol.Exp.Ther_361_408 |
Author(s) : Trindade-da-Silva CA , Bettaieb A , Napimoga MH , Lee KSS , Inceoglu B , Ueira-Vieira C , Bruun D , Goswami SK , Haj FG , Hammock BD |
Ref : Journal of Pharmacology & Experimental Therapeutics , 361 :408 , 2017 |
Abstract : Trindade-da-Silva_2017_J.Pharmacol.Exp.Ther_361_408 |
ESTHER : Trindade-da-Silva_2017_J.Pharmacol.Exp.Ther_361_408 |
PubMedSearch : Trindade-da-Silva_2017_J.Pharmacol.Exp.Ther_361_408 |
PubMedID: 28356494 |
Trindade-da-Silva CA, Bettaieb A, Napimoga MH, Lee KSS, Inceoglu B, Ueira-Vieira C, Bruun D, Goswami SK, Haj FG, Hammock BD (2017)
Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis
Journal of Pharmacology & Experimental Therapeutics
361 :408
Trindade-da-Silva CA, Bettaieb A, Napimoga MH, Lee KSS, Inceoglu B, Ueira-Vieira C, Bruun D, Goswami SK, Haj FG, Hammock BD (2017)
Journal of Pharmacology & Experimental Therapeutics
361 :408